Circulating Tumors Cells as a Biomarker of Radiation Benefit. Read more about Circulating Tumors Cells as a Biomarker of Radiation Benefit.
Association of Statin Use With Overall and Cancer Survival. Read more about Association of Statin Use With Overall and Cancer Survival.
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial. Read more about Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial. Read more about Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.
Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. Read more about Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Data-Driven Mammography Screening Practices-Reply. Read more about Data-Driven Mammography Screening Practices-Reply.
HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer. Read more about HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer.
Trends in Cancer Survival by Health Insurance Status in California From 1997 to 2014. Read more about Trends in Cancer Survival by Health Insurance Status in California From 1997 to 2014.
Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial. Read more about Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial.
Declining Incidence Rates of Prostate Cancer in the United States: Is This Good News or Not? Read more about Declining Incidence Rates of Prostate Cancer in the United States: Is This Good News or Not?
